Professional US stock economic sensitivity analysis and beta calculations to understand market correlation and portfolio risk exposure to market movements. We help you position your portfolio appropriately based on your risk tolerance and overall market outlook and expectations. We provide beta analysis, sensitivity testing, and correlation to market factors for comprehensive risk assessment. Understand risk exposure with our comprehensive sensitivity analysis and beta calculations for better portfolio construction.
Hercules Capital Inc. 6.25% Notes due 2033 (HCXY), a long-dated fixed income instrument issued by leading business development company (BDC) Hercules Capital, is trading at $25.13 as of 2026-04-08, marking a 0.77% gain on the day. This analysis explores key technical levels, recent market context, and potential near-term price scenarios for HCXY, as yield-focused investors continue to assess opportunities in the corporate credit space amid shifting macroeconomic conditions. No recent earnings da
Is Hercules (HCXY) Stock Near a Bottom | Price at $25.13, Up 0.77% - Debt Free Stocks
HCXY - Stock Analysis
3372 Comments
1837 Likes
1
Brescia
Consistent User
2 hours ago
If only I had checked this sooner.
👍 74
Reply
2
Chain
Insight Reader
5 hours ago
This feels like a beginning and an ending.
👍 22
Reply
3
Irham
Consistent User
1 day ago
I understood nothing but reacted anyway.
👍 123
Reply
4
Jackalin
Active Reader
1 day ago
This feels like something is watching me.
👍 137
Reply
5
Beautrice
Senior Contributor
2 days ago
Ah, if only I had caught this before. 😔
👍 247
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.